Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
AstraZeneca PLC banner

AstraZeneca PLC
F:ZEGA

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
F:ZEGA
Watchlist
Price: 75.5 EUR -3.82% Market Closed
Market Cap: €234.1B
Write Note Create Alert

Intrinsic Value

Is ZEGA undervalued or overvalued?

See the intrinsic value estimate for AstraZeneca PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

ZEGA Intrinsic Value
LOCKED
Unlock
Today vs. history

ZEGA looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with ZEGA’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor ZEGA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €75.5
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to ZEGA

Fundamental Analysis

What AstraZeneca Does

Pharmaceuticals Health Care

AstraZeneca is a global pharmaceutical company that discovers, develops, and sells prescription medicines. Its drugs treat major illnesses such as cancer, heart and kidney disease, respiratory conditions, and rare diseases. The company works with doctors, hospitals, and health systems, and it earns money mainly by selling patented medicines and, in some cases, by licensing or partnering on drug programs.

Headquarters
United Kingdom UK
Employees
96 100
IPO date
Sep 21, 2007
Read the full company overview
View Company Overview

AstraZeneca has a wide economic moat

No Moat Narrow Wide

Patents and exclusive rights to sell approved medicines prevent rivals from offering cheaper copies of AstraZeneca’s protected treatments. Its range of protected drugs and continuing development of new medicines spread that protection across several diseases rather than relying on a single product.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
AstraZeneca PLC

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Continue ZEGA Research

Summary
ZEGA intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZEGA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZEGA stock valuation using valuation multiples.
Wall St Estimates
ZEGA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZEGA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other AstraZeneca PLC listings:
LSE • GBX
AZN
 F • EUR
ZEG
 XHAM • EUR
ZEG
 STO • SEK
AZN
 XMUN • EUR
ZEG
 SWB • EUR
ZEG
 NYSE • USD
AZN
 DUS • EUR
ZEG
Discover More
What is the Intrinsic Value of one ZEGA stock?

The intrinsic value for AstraZeneca PLC (ZEGA) under the Base Case is hidden EUR.

Is ZEGA stock undervalued or overvalued?

Compared with the current market price of 75.5 EUR, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 363,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.